nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SCN1A—migraine	0.256	0.531	CbGaD
Procainamide—SCN2A—migraine	0.226	0.469	CbGaD
Procainamide—SCN1A—Topiramate—migraine	0.0479	0.15	CbGbCtD
Procainamide—SLC22A4—Verapamil—migraine	0.0447	0.139	CbGbCtD
Procainamide—SLC22A2—Propranolol—migraine	0.0351	0.109	CbGbCtD
Procainamide—SCN5A—Topiramate—migraine	0.0328	0.102	CbGbCtD
Procainamide—SCN5A—Verapamil—migraine	0.0316	0.0986	CbGbCtD
Procainamide—SLC22A5—Valproic Acid—migraine	0.029	0.0905	CbGbCtD
Procainamide—SLC22A5—Verapamil—migraine	0.0252	0.0788	CbGbCtD
Procainamide—SLC22A1—Verapamil—migraine	0.0209	0.0653	CbGbCtD
Procainamide—CHRM2—Amitriptyline—migraine	0.0209	0.0651	CbGbCtD
Procainamide—CYP2D6—Timolol—migraine	0.00987	0.0308	CbGbCtD
Procainamide—CYP2D6—Propranolol—migraine	0.0088	0.0275	CbGbCtD
Procainamide—CYP2D6—Amitriptyline—migraine	0.00761	0.0237	CbGbCtD
Procainamide—CYP2D6—Verapamil—migraine	0.00604	0.0188	CbGbCtD
Procainamide—SCN3A—spinal nerve—migraine	0.00506	0.119	CbGeAlD
Procainamide—Antinuclear antibody positive—Amitriptyline—migraine	0.004	0.0476	CcSEcCtD
Procainamide—Electrocardiogram QRS complex—Amitriptyline—migraine	0.004	0.0476	CcSEcCtD
Procainamide—QRS complex—Amitriptyline—migraine	0.004	0.0476	CcSEcCtD
Procainamide—Lupus-like syndrome—Amitriptyline—migraine	0.00385	0.0459	CcSEcCtD
Procainamide—SCN11A—peripheral nervous system—migraine	0.0027	0.0637	CbGeAlD
Procainamide—Atrioventricular block second degree—Propranolol—migraine	0.00259	0.0308	CcSEcCtD
Procainamide—SCN11A—nerve—migraine	0.00211	0.0497	CbGeAlD
Procainamide—SCN8A—peripheral nervous system—migraine	0.00205	0.0483	CbGeAlD
Procainamide—Function kidney decreased—Gabapentin—migraine	0.00183	0.0218	CcSEcCtD
Procainamide—SCN8A—nerve—migraine	0.0016	0.0376	CbGeAlD
Procainamide—SCN10A—peripheral nervous system—migraine	0.00137	0.0323	CbGeAlD
Procainamide—Gastrointestinal tract irritation—Valproic Acid—migraine	0.00135	0.0161	CcSEcCtD
Procainamide—Systemic lupus erythematosus—Propranolol—migraine	0.00133	0.0159	CcSEcCtD
Procainamide—Lupus erythematosus—Valproic Acid—migraine	0.00129	0.0154	CcSEcCtD
Procainamide—Ventricular fibrillation—Amitriptyline—migraine	0.00119	0.0141	CcSEcCtD
Procainamide—Lupus erythematosus—Timolol—migraine	0.00115	0.0137	CcSEcCtD
Procainamide—SCN10A—nerve—migraine	0.00107	0.0252	CbGeAlD
Procainamide—SCN11A—trigeminal ganglion—migraine	0.00102	0.0241	CbGeAlD
Procainamide—SCN11A—L1CAM interactions—SCN1A—migraine	0.000939	0.014	CbGpPWpGaD
Procainamide—Pericarditis—Gabapentin—migraine	0.000924	0.011	CcSEcCtD
Procainamide—Ventricular tachycardia—Amitriptyline—migraine	0.000908	0.0108	CcSEcCtD
Procainamide—SCN7A—L1CAM interactions—SCN2A—migraine	0.000896	0.0134	CbGpPWpGaD
Procainamide—Systemic lupus erythematosus—Valproic Acid—migraine	0.000871	0.0104	CcSEcCtD
Procainamide—SCN7A—trigeminal ganglion—migraine	0.000869	0.0205	CbGeAlD
Procainamide—SCN8A—L1CAM interactions—SCN1A—migraine	0.000859	0.0128	CbGpPWpGaD
Procainamide—SCN11A—L1CAM interactions—SCN2A—migraine	0.000799	0.0119	CbGpPWpGaD
Procainamide—Systemic lupus erythematosus—Timolol—migraine	0.000775	0.00924	CcSEcCtD
Procainamide—Hepatic failure—Amitriptyline—migraine	0.000733	0.00874	CcSEcCtD
Procainamide—SCN8A—L1CAM interactions—SCN2A—migraine	0.000731	0.0109	CbGpPWpGaD
Procainamide—Hepatic enzyme increased—Verapamil—migraine	0.000719	0.00857	CcSEcCtD
Procainamide—Vasculitis—Verapamil—migraine	0.000697	0.0083	CcSEcCtD
Procainamide—SCN9A—L1CAM interactions—SCN1A—migraine	0.000695	0.0104	CbGpPWpGaD
Procainamide—SLC22A3—Synaptic Vesicle Pathway—ATP1A2—migraine	0.000693	0.0103	CbGpPWpGaD
Procainamide—SCN8A—brainstem—migraine	0.000686	0.0162	CbGeAlD
Procainamide—SCN9A—trigeminal ganglion—migraine	0.000681	0.016	CbGeAlD
Procainamide—Arthritis—Amitriptyline—migraine	0.000678	0.00808	CcSEcCtD
Procainamide—DNMT1—trigeminal ganglion—migraine	0.000668	0.0157	CbGeAlD
Procainamide—SCN3A—L1CAM interactions—SCN1A—migraine	0.000665	0.0099	CbGpPWpGaD
Procainamide—Lightheadedness—Propranolol—migraine	0.000661	0.00788	CcSEcCtD
Procainamide—Proparacaine—SCN1A—migraine	0.000641	0.138	CrCbGaD
Procainamide—SCN2A—L1CAM interactions—SCN1A—migraine	0.000639	0.00952	CbGpPWpGaD
Procainamide—SCN4A—L1CAM interactions—SCN1A—migraine	0.000639	0.00952	CbGpPWpGaD
Procainamide—Pleural effusion—Valproic Acid—migraine	0.000629	0.0075	CcSEcCtD
Procainamide—SCN7A—cardiovascular system—migraine	0.000628	0.0148	CbGeAlD
Procainamide—Rash maculo-papular—Verapamil—migraine	0.000618	0.00736	CcSEcCtD
Procainamide—SCN10A—L1CAM interactions—SCN1A—migraine	0.000616	0.00918	CbGpPWpGaD
Procainamide—Hepatomegaly—Timolol—migraine	0.000606	0.00722	CcSEcCtD
Procainamide—SCN9A—L1CAM interactions—SCN2A—migraine	0.000591	0.00881	CbGpPWpGaD
Procainamide—Oxybuprocaine—SCN1A—migraine	0.000587	0.127	CrCbGaD
Procainamide—Proparacaine—SCN2A—migraine	0.000566	0.122	CrCbGaD
Procainamide—SCN3A—L1CAM interactions—SCN2A—migraine	0.000565	0.00842	CbGpPWpGaD
Procainamide—Hepatomegaly—Gabapentin—migraine	0.000565	0.00673	CcSEcCtD
Procainamide—Eosinophilia—Amitriptyline—migraine	0.000564	0.00672	CcSEcCtD
Procainamide—SLC22A2—trigeminal ganglion—migraine	0.000558	0.0131	CbGeAlD
Procainamide—Lethargy—Propranolol—migraine	0.000547	0.00652	CcSEcCtD
Procainamide—SCN4A—L1CAM interactions—SCN2A—migraine	0.000543	0.00809	CbGpPWpGaD
Procainamide—ACHE—trigeminal ganglion—migraine	0.000543	0.0128	CbGeAlD
Procainamide—SCN10A—L1CAM interactions—SCN2A—migraine	0.000524	0.0078	CbGpPWpGaD
Procainamide—SCN1A—L1CAM interactions—SCN2A—migraine	0.000524	0.0078	CbGpPWpGaD
Procainamide—SCN10A—trigeminal ganglion—migraine	0.000518	0.0122	CbGeAlD
Procainamide—SCN1A—brainstem—migraine	0.000518	0.0122	CbGeAlD
Procainamide—Oxybuprocaine—SCN2A—migraine	0.000517	0.112	CrCbGaD
Procainamide—DNMT1—One Carbon Metabolism—MTHFR—migraine	0.000512	0.00763	CbGpPWpGaD
Procainamide—Cardiac arrest—Propranolol—migraine	0.00051	0.00608	CcSEcCtD
Procainamide—Hepatic enzyme increased—Valproic Acid—migraine	0.00051	0.00607	CcSEcCtD
Procainamide—Cardiac failure—Verapamil—migraine	0.000506	0.00603	CcSEcCtD
Procainamide—Lethargy—Verapamil—migraine	0.000504	0.006	CcSEcCtD
Procainamide—SLC22A3—Synaptic Vesicle Pathway—CACNA1A—migraine	0.000501	0.00746	CbGpPWpGaD
Procainamide—SCN11A—head—migraine	0.0005	0.0118	CbGeAlD
Procainamide—Vasculitis—Valproic Acid—migraine	0.000494	0.00589	CcSEcCtD
Procainamide—DNMT1—cardiovascular system—migraine	0.000482	0.0114	CbGeAlD
Procainamide—Psychotic disorder—Verapamil—migraine	0.000482	0.00574	CcSEcCtD
Procainamide—SLC22A4—neck—migraine	0.000479	0.0113	CbGeAlD
Procainamide—SCN2A—brainstem—migraine	0.000476	0.0112	CbGeAlD
Procainamide—SCN11A—nervous system—migraine	0.000474	0.0112	CbGeAlD
Procainamide—Agranulocytosis—Amitriptyline—migraine	0.000474	0.00565	CcSEcCtD
Procainamide—Cardiac arrest—Verapamil—migraine	0.000469	0.00559	CcSEcCtD
Procainamide—DNMT1—Trans-sulfuration and one carbon metabolism—MTHFR—migraine	0.00046	0.00686	CbGpPWpGaD
Procainamide—SCN11A—central nervous system—migraine	0.000456	0.0108	CbGeAlD
Procainamide—Chloroprocaine—HTR3A—migraine	0.000456	0.0984	CrCbGaD
Procainamide—Hallucination—Amitriptyline—migraine	0.000453	0.0054	CcSEcCtD
Procainamide—Rash maculo-papular—Valproic Acid—migraine	0.000438	0.00522	CcSEcCtD
Procainamide—Procaine—HTR3A—migraine	0.000435	0.0939	CrCbGaD
Procainamide—Neutropenia—Propranolol—migraine	0.000434	0.00517	CcSEcCtD
Procainamide—SCN5A—L1CAM interactions—SCN1A—migraine	0.000433	0.00645	CbGpPWpGaD
Procainamide—SCN7A—head—migraine	0.000425	0.01	CbGeAlD
Procainamide—Benzocaine—SCN1A—migraine	0.000413	0.0892	CrCbGaD
Procainamide—Depression—Propranolol—migraine	0.000412	0.00491	CcSEcCtD
Procainamide—Abdominal discomfort—Verapamil—migraine	0.000409	0.00487	CcSEcCtD
Procainamide—SCN7A—Axon guidance—SCN1A—migraine	0.000398	0.00594	CbGpPWpGaD
Procainamide—Hepatic failure—Valproic Acid—migraine	0.000389	0.00464	CcSEcCtD
Procainamide—Dysgeusia—Amitriptyline—migraine	0.000389	0.00463	CcSEcCtD
Procainamide—Agranulocytosis—Propranolol—migraine	0.000386	0.0046	CcSEcCtD
Procainamide—SCN8A—head—migraine	0.000379	0.00893	CbGeAlD
Procainamide—Bradycardia—Propranolol—migraine	0.000378	0.0045	CcSEcCtD
Procainamide—SLC22A3—trigeminal ganglion—migraine	0.000377	0.00887	CbGeAlD
Procainamide—Hallucination—Propranolol—migraine	0.000369	0.0044	CcSEcCtD
Procainamide—Ill-defined disorder—Amitriptyline—migraine	0.000368	0.00439	CcSEcCtD
Procainamide—SCN5A—L1CAM interactions—SCN2A—migraine	0.000368	0.00549	CbGpPWpGaD
Procainamide—Oliguria—Topiramate—migraine	0.000365	0.00435	CcSEcCtD
Procainamide—Benzocaine—SCN2A—migraine	0.000364	0.0787	CrCbGaD
Procainamide—CHRM2—Monoamine GPCRs—HTR1D—migraine	0.000364	0.00542	CbGpPWpGaD
Procainamide—Rash maculo-papular—Gabapentin—migraine	0.000363	0.00433	CcSEcCtD
Procainamide—SCN11A—brain—migraine	0.000362	0.00854	CbGeAlD
Procainamide—SCN8A—nervous system—migraine	0.000359	0.00847	CbGeAlD
Procainamide—Malaise—Amitriptyline—migraine	0.000358	0.00426	CcSEcCtD
Procainamide—Lethargy—Valproic Acid—migraine	0.000357	0.00425	CcSEcCtD
Procainamide—Hepatic enzyme increased—Topiramate—migraine	0.000355	0.00424	CcSEcCtD
Procainamide—SCN11A—Axon guidance—SCN1A—migraine	0.000355	0.00529	CbGpPWpGaD
Procainamide—Metoclopramide—HTR3A—migraine	0.000355	0.0765	CrCbGaD
Procainamide—Bradycardia—Verapamil—migraine	0.000348	0.00414	CcSEcCtD
Procainamide—SCN8A—central nervous system—migraine	0.000346	0.00815	CbGeAlD
Procainamide—Cardiac disorder—Propranolol—migraine	0.000344	0.0041	CcSEcCtD
Procainamide—Convulsion—Amitriptyline—migraine	0.000344	0.0041	CcSEcCtD
Procainamide—Psychotic disorder—Valproic Acid—migraine	0.000342	0.00407	CcSEcCtD
Procainamide—SCN5A—cardiovascular system—migraine	0.00034	0.00802	CbGeAlD
Procainamide—SCN7A—Axon guidance—SCN2A—migraine	0.000339	0.00505	CbGpPWpGaD
Procainamide—CHRM2—Monoamine GPCRs—HTR2B—migraine	0.000338	0.00504	CbGpPWpGaD
Procainamide—SCN8A—cerebellum—migraine	0.000338	0.00797	CbGeAlD
Procainamide—Discomfort—Amitriptyline—migraine	0.000334	0.00398	CcSEcCtD
Procainamide—DNMT1—head—migraine	0.000327	0.0077	CbGeAlD
Procainamide—Confusional state—Amitriptyline—migraine	0.000327	0.00389	CcSEcCtD
Procainamide—SCN8A—Axon guidance—SCN1A—migraine	0.000325	0.00484	CbGpPWpGaD
Procainamide—Hepatic failure—Gabapentin—migraine	0.000323	0.00385	CcSEcCtD
Procainamide—Abdominal pain upper—Valproic Acid—migraine	0.00032	0.00381	CcSEcCtD
Procainamide—Cardiac failure—Timolol—migraine	0.000319	0.0038	CcSEcCtD
Procainamide—Shock—Amitriptyline—migraine	0.000319	0.0038	CcSEcCtD
Procainamide—Thrombocytopenia—Amitriptyline—migraine	0.000317	0.00378	CcSEcCtD
Procainamide—Flushing—Verapamil—migraine	0.000317	0.00378	CcSEcCtD
Procainamide—DNMT1—nervous system—migraine	0.00031	0.0073	CbGeAlD
Procainamide—ACHE—Monoamine Transport—SLC6A4—migraine	0.000309	0.0046	CbGpPWpGaD
Procainamide—Anorexia—Amitriptyline—migraine	0.000309	0.00368	CcSEcCtD
Procainamide—SCN7A—brain—migraine	0.000308	0.00726	CbGeAlD
Procainamide—Atrial fibrillation—Gabapentin—migraine	0.000306	0.00365	CcSEcCtD
Procainamide—CHRM2—Amine ligand-binding receptors—HTR1D—migraine	0.000306	0.00456	CbGpPWpGaD
Procainamide—Rash maculo-papular—Topiramate—migraine	0.000306	0.00364	CcSEcCtD
Procainamide—Renal impairment—Gabapentin—migraine	0.000305	0.00363	CcSEcCtD
Procainamide—Hypotension—Amitriptyline—migraine	0.000303	0.00361	CcSEcCtD
Procainamide—SCN11A—Axon guidance—SCN2A—migraine	0.000302	0.0045	CbGpPWpGaD
Procainamide—Eosinophilia—Valproic Acid—migraine	0.000299	0.00357	CcSEcCtD
Procainamide—Arthritis—Gabapentin—migraine	0.000298	0.00356	CcSEcCtD
Procainamide—DNMT1—central nervous system—migraine	0.000298	0.00703	CbGeAlD
Procainamide—Cardiac failure—Gabapentin—migraine	0.000297	0.00354	CcSEcCtD
Procainamide—Lidocaine—SCN2A—migraine	0.000297	0.0641	CrCbGaD
Procainamide—SCN4A—head—migraine	0.000297	0.007	CbGeAlD
Procainamide—Cardiac arrest—Timolol—migraine	0.000296	0.00353	CcSEcCtD
Procainamide—Lethargy—Gabapentin—migraine	0.000296	0.00353	CcSEcCtD
Procainamide—SCN5A—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000294	0.00437	CbGpPWpGaD
Procainamide—DNMT1—cerebellum—migraine	0.000291	0.00687	CbGeAlD
Procainamide—Abdominal discomfort—Valproic Acid—migraine	0.00029	0.00345	CcSEcCtD
Procainamide—CHRM2—cardiovascular system—migraine	0.00029	0.00683	CbGeAlD
Procainamide—SCN1A—head—migraine	0.000286	0.00675	CbGeAlD
Procainamide—Abdominal pain upper—Timolol—migraine	0.000284	0.00339	CcSEcCtD
Procainamide—SCN7A—Developmental Biology—SCN1A—migraine	0.000284	0.00424	CbGpPWpGaD
Procainamide—CHRM2—Amine ligand-binding receptors—HTR2B—migraine	0.000284	0.00423	CbGpPWpGaD
Procainamide—Psychotic disorder—Gabapentin—migraine	0.000283	0.00338	CcSEcCtD
Procainamide—Neutropenia—Valproic Acid—migraine	0.000283	0.00337	CcSEcCtD
Procainamide—SCN4A—nervous system—migraine	0.000282	0.00664	CbGeAlD
Procainamide—Decreased appetite—Amitriptyline—migraine	0.000281	0.00335	CcSEcCtD
Procainamide—Convulsion—Propranolol—migraine	0.00028	0.00334	CcSEcCtD
Procainamide—SCN8A—Axon guidance—SCN2A—migraine	0.000276	0.00411	CbGpPWpGaD
Procainamide—Cardiac arrest—Gabapentin—migraine	0.000276	0.00329	CcSEcCtD
Procainamide—SCN8A—brain—migraine	0.000275	0.00647	CbGeAlD
Procainamide—SLC22A5—trigeminal ganglion—migraine	0.000274	0.00645	CbGeAlD
Procainamide—SCN1A—nervous system—migraine	0.000272	0.0064	CbGeAlD
Procainamide—Angioedema—Verapamil—migraine	0.000272	0.00324	CcSEcCtD
Procainamide—Hepatic failure—Topiramate—migraine	0.000272	0.00324	CcSEcCtD
Procainamide—SCN4A—central nervous system—migraine	0.000271	0.00639	CbGeAlD
Procainamide—SLC22A3—Synaptic Vesicle Pathway—SLC6A4—migraine	0.00027	0.00403	CbGpPWpGaD
Procainamide—Depression—Valproic Acid—migraine	0.000269	0.0032	CcSEcCtD
Procainamide—Feeling abnormal—Amitriptyline—migraine	0.000267	0.00318	CcSEcCtD
Procainamide—BCHE—trigeminal ganglion—migraine	0.000267	0.00628	CbGeAlD
Procainamide—SCN2A—head—migraine	0.000263	0.0062	CbGeAlD
Procainamide—SCN9A—Axon guidance—SCN1A—migraine	0.000263	0.00391	CbGpPWpGaD
Procainamide—SCN1A—central nervous system—migraine	0.000261	0.00616	CbGeAlD
Procainamide—Convulsion—Verapamil—migraine	0.000257	0.00307	CcSEcCtD
Procainamide—Urticaria—Amitriptyline—migraine	0.000257	0.00307	CcSEcCtD
Procainamide—Body temperature increased—Amitriptyline—migraine	0.000256	0.00305	CcSEcCtD
Procainamide—SCN1A—cerebellum—migraine	0.000256	0.00602	CbGeAlD
Procainamide—SCN10A—head—migraine	0.000254	0.00597	CbGeAlD
Procainamide—SCN11A—Developmental Biology—SCN1A—migraine	0.000253	0.00378	CbGpPWpGaD
Procainamide—Myalgia—Verapamil—migraine	0.000253	0.00302	CcSEcCtD
Procainamide—Arthralgia—Verapamil—migraine	0.000253	0.00302	CcSEcCtD
Procainamide—Agranulocytosis—Valproic Acid—migraine	0.000252	0.003	CcSEcCtD
Procainamide—SCN3A—Axon guidance—SCN1A—migraine	0.000251	0.00374	CbGpPWpGaD
Procainamide—Discomfort—Verapamil—migraine	0.00025	0.00298	CcSEcCtD
Procainamide—SCN5A—SIDS Susceptibility Pathways—HTR3A—migraine	0.00025	0.00372	CbGpPWpGaD
Procainamide—SCN2A—nervous system—migraine	0.000249	0.00587	CbGeAlD
Procainamide—Lethargy—Topiramate—migraine	0.000249	0.00297	CcSEcCtD
Procainamide—Eosinophilia—Gabapentin—migraine	0.000248	0.00296	CcSEcCtD
Procainamide—Bradycardia—Valproic Acid—migraine	0.000246	0.00294	CcSEcCtD
Procainamide—Confusional state—Verapamil—migraine	0.000245	0.00291	CcSEcCtD
Procainamide—SCN7A—Developmental Biology—SCN2A—migraine	0.000242	0.0036	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—SCN1A—migraine	0.000241	0.0036	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—SCN1A—migraine	0.000241	0.0036	CbGpPWpGaD
Procainamide—SCN9A—brain—migraine	0.000241	0.00569	CbGeAlD
Procainamide—Hallucination—Valproic Acid—migraine	0.000241	0.00287	CcSEcCtD
Procainamide—SCN10A—nervous system—migraine	0.00024	0.00566	CbGeAlD
Procainamide—SCN2A—central nervous system—migraine	0.00024	0.00566	CbGeAlD
Procainamide—Depression—Timolol—migraine	0.000239	0.00285	CcSEcCtD
Procainamide—Shock—Verapamil—migraine	0.000239	0.00284	CcSEcCtD
Procainamide—Psychotic disorder—Topiramate—migraine	0.000238	0.00284	CcSEcCtD
Procainamide—ACHE—cerebellum—migraine	0.000237	0.00558	CbGeAlD
Procainamide—DNMT1—brain—migraine	0.000237	0.00558	CbGeAlD
Procainamide—BCHE—brainstem—migraine	0.000236	0.00556	CbGeAlD
Procainamide—SCN2A—cerebellum—migraine	0.000235	0.00553	CbGeAlD
Procainamide—SCN10A—Axon guidance—SCN1A—migraine	0.000233	0.00347	CbGpPWpGaD
Procainamide—Asthenia—Amitriptyline—migraine	0.000232	0.00277	CcSEcCtD
Procainamide—SCN8A—Developmental Biology—SCN1A—migraine	0.000232	0.00345	CbGpPWpGaD
Procainamide—SCN10A—central nervous system—migraine	0.000231	0.00545	CbGeAlD
Procainamide—SCN3A—head—migraine	0.000231	0.00545	CbGeAlD
Procainamide—SCN5A—head—migraine	0.00023	0.00543	CbGeAlD
Procainamide—Decreased appetite—Propranolol—migraine	0.000229	0.00273	CcSEcCtD
Procainamide—Pruritus—Amitriptyline—migraine	0.000229	0.00273	CcSEcCtD
Procainamide—Hypotension—Verapamil—migraine	0.000227	0.0027	CcSEcCtD
Procainamide—Agranulocytosis—Timolol—migraine	0.000224	0.00267	CcSEcCtD
Procainamide—SCN9A—Axon guidance—SCN2A—migraine	0.000223	0.00333	CbGpPWpGaD
Procainamide—Depression—Gabapentin—migraine	0.000223	0.00266	CcSEcCtD
Procainamide—Abdominal pain upper—Topiramate—migraine	0.000223	0.00266	CcSEcCtD
Procainamide—Diarrhoea—Amitriptyline—migraine	0.000222	0.00264	CcSEcCtD
Procainamide—SCN7A—Developmental Biology—MEF2D—migraine	0.000221	0.00329	CbGpPWpGaD
Procainamide—Musculoskeletal discomfort—Verapamil—migraine	0.000221	0.00263	CcSEcCtD
Procainamide—CHRM2—Monoamine GPCRs—HTR1B—migraine	0.00022	0.00328	CbGpPWpGaD
Procainamide—Renal failure—Gabapentin—migraine	0.00022	0.00262	CcSEcCtD
Procainamide—Bradycardia—Timolol—migraine	0.000219	0.00261	CcSEcCtD
Procainamide—SCN3A—nervous system—migraine	0.000219	0.00516	CbGeAlD
Procainamide—SCN5A—nervous system—migraine	0.000218	0.00515	CbGeAlD
Procainamide—Chills—Valproic Acid—migraine	0.000217	0.00259	CcSEcCtD
Procainamide—Gastrointestinal pain—Propranolol—migraine	0.000216	0.00257	CcSEcCtD
Procainamide—SCN11A—Developmental Biology—SCN2A—migraine	0.000215	0.00321	CbGpPWpGaD
Procainamide—SCN4A—brain—migraine	0.000215	0.00507	CbGeAlD
Procainamide—Hallucination—Timolol—migraine	0.000214	0.00255	CcSEcCtD
Procainamide—Dizziness—Amitriptyline—migraine	0.000214	0.00255	CcSEcCtD
Procainamide—SCN3A—Axon guidance—SCN2A—migraine	0.000214	0.00318	CbGpPWpGaD
Procainamide—CHRM2—Monoamine GPCRs—HTR1A—migraine	0.000212	0.00316	CbGpPWpGaD
Procainamide—SCN3A—central nervous system—migraine	0.000211	0.00497	CbGeAlD
Procainamide—SCN5A—central nervous system—migraine	0.00021	0.00496	CbGeAlD
Procainamide—Urticaria—Propranolol—migraine	0.000209	0.0025	CcSEcCtD
Procainamide—Eosinophilia—Topiramate—migraine	0.000209	0.00249	CcSEcCtD
Procainamide—Body temperature increased—Propranolol—migraine	0.000208	0.00248	CcSEcCtD
Procainamide—Abdominal pain—Propranolol—migraine	0.000208	0.00248	CcSEcCtD
Procainamide—SCN1A—brain—migraine	0.000208	0.00489	CbGeAlD
Procainamide—ACHE—Neuronal System—KCNK18—migraine	0.000207	0.00309	CbGpPWpGaD
Procainamide—Dysgeusia—Valproic Acid—migraine	0.000206	0.00246	CcSEcCtD
Procainamide—SCN3A—cerebellum—migraine	0.000206	0.00486	CbGeAlD
Procainamide—Vomiting—Amitriptyline—migraine	0.000206	0.00245	CcSEcCtD
Procainamide—SCN4A—Axon guidance—SCN2A—migraine	0.000205	0.00306	CbGpPWpGaD
Procainamide—CHRM2—Monoamine GPCRs—HTR2C—migraine	0.000205	0.00305	CbGpPWpGaD
Procainamide—Bradycardia—Gabapentin—migraine	0.000204	0.00243	CcSEcCtD
Procainamide—Abdominal discomfort—Topiramate—migraine	0.000202	0.00241	CcSEcCtD
Procainamide—Cardiac disorder—Timolol—migraine	0.0002	0.00238	CcSEcCtD
Procainamide—Feeling abnormal—Verapamil—migraine	0.0002	0.00238	CcSEcCtD
Procainamide—Hallucination—Gabapentin—migraine	0.0002	0.00238	CcSEcCtD
Procainamide—SCN10A—Axon guidance—SCN2A—migraine	0.000198	0.00295	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—SCN2A—migraine	0.000198	0.00295	CbGpPWpGaD
Procainamide—Neutropenia—Topiramate—migraine	0.000197	0.00235	CcSEcCtD
Procainamide—SCN8A—Developmental Biology—SCN2A—migraine	0.000197	0.00294	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—MEF2D—migraine	0.000197	0.00294	CbGpPWpGaD
Procainamide—CHRM2—head—migraine	0.000196	0.00462	CbGeAlD
Procainamide—Ill-defined disorder—Valproic Acid—migraine	0.000195	0.00233	CcSEcCtD
Procainamide—Hypersensitivity—Propranolol—migraine	0.000194	0.00231	CcSEcCtD
Procainamide—Urticaria—Verapamil—migraine	0.000193	0.0023	CcSEcCtD
Procainamide—SLC22A1—head—migraine	0.000193	0.00454	CbGeAlD
Procainamide—BCHE—cardiovascular system—migraine	0.000193	0.00454	CbGeAlD
Procainamide—Angioedema—Valproic Acid—migraine	0.000193	0.00229	CcSEcCtD
Procainamide—Nausea—Amitriptyline—migraine	0.000192	0.00229	CcSEcCtD
Procainamide—ACHE—brain—migraine	0.000192	0.00453	CbGeAlD
Procainamide—SCN2A—brain—migraine	0.000191	0.00449	CbGeAlD
Procainamide—Malaise—Valproic Acid—migraine	0.00019	0.00226	CcSEcCtD
Procainamide—Asthenia—Propranolol—migraine	0.000189	0.00225	CcSEcCtD
Procainamide—Depression—Topiramate—migraine	0.000188	0.00223	CcSEcCtD
Procainamide—SCN9A—Developmental Biology—SCN1A—migraine	0.000187	0.00279	CbGpPWpGaD
Procainamide—Cardiac disorder—Gabapentin—migraine	0.000186	0.00222	CcSEcCtD
Procainamide—CHRM2—nervous system—migraine	0.000186	0.00438	CbGeAlD
Procainamide—CHRM2—Amine ligand-binding receptors—HTR1B—migraine	0.000185	0.00276	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—KCNK18—migraine	0.000185	0.00276	CbGpPWpGaD
Procainamide—Renal failure—Topiramate—migraine	0.000185	0.0022	CcSEcCtD
Procainamide—SLC22A3—head—migraine	0.000184	0.00434	CbGeAlD
Procainamide—SCN10A—brain—migraine	0.000184	0.00433	CbGeAlD
Procainamide—Dysgeusia—Timolol—migraine	0.000184	0.00219	CcSEcCtD
Procainamide—SLC22A1—nervous system—migraine	0.000183	0.0043	CbGeAlD
Procainamide—SLC22A4—cerebellum—migraine	0.000181	0.00425	CbGeAlD
Procainamide—Diarrhoea—Propranolol—migraine	0.00018	0.00215	CcSEcCtD
Procainamide—SCN8A—Developmental Biology—MEF2D—migraine	0.00018	0.00269	CbGpPWpGaD
Procainamide—Chills—Gabapentin—migraine	0.00018	0.00215	CcSEcCtD
Procainamide—CHRM2—Monoamine GPCRs—HTR7—migraine	0.000179	0.00267	CbGpPWpGaD
Procainamide—Myalgia—Valproic Acid—migraine	0.000179	0.00214	CcSEcCtD
Procainamide—Arthralgia—Valproic Acid—migraine	0.000179	0.00214	CcSEcCtD
Procainamide—SCN3A—Developmental Biology—SCN1A—migraine	0.000179	0.00267	CbGpPWpGaD
Procainamide—CHRM2—central nervous system—migraine	0.000179	0.00422	CbGeAlD
Procainamide—Hypersensitivity—Verapamil—migraine	0.000179	0.00213	CcSEcCtD
Procainamide—CHRM2—Amine ligand-binding receptors—HTR1A—migraine	0.000178	0.00266	CbGpPWpGaD
Procainamide—Discomfort—Valproic Acid—migraine	0.000177	0.00211	CcSEcCtD
Procainamide—SLC22A1—central nervous system—migraine	0.000176	0.00414	CbGeAlD
Procainamide—Agranulocytosis—Topiramate—migraine	0.000175	0.00209	CcSEcCtD
Procainamide—SLC22A3—nervous system—migraine	0.000175	0.00411	CbGeAlD
Procainamide—Dizziness—Propranolol—migraine	0.000174	0.00208	CcSEcCtD
Procainamide—Asthenia—Verapamil—migraine	0.000174	0.00207	CcSEcCtD
Procainamide—Confusional state—Valproic Acid—migraine	0.000173	0.00207	CcSEcCtD
Procainamide—SCN4A—Developmental Biology—SCN1A—migraine	0.000172	0.00257	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—SCN1A—migraine	0.000172	0.00257	CbGpPWpGaD
Procainamide—CHRM2—Amine ligand-binding receptors—HTR2C—migraine	0.000172	0.00257	CbGpPWpGaD
Procainamide—Bradycardia—Topiramate—migraine	0.000172	0.00205	CcSEcCtD
Procainamide—Pruritus—Verapamil—migraine	0.000172	0.00204	CcSEcCtD
Procainamide—Angioedema—Timolol—migraine	0.000171	0.00204	CcSEcCtD
Procainamide—Dysgeusia—Gabapentin—migraine	0.000171	0.00204	CcSEcCtD
Procainamide—Thrombocytopenia—Valproic Acid—migraine	0.000168	0.00201	CcSEcCtD
Procainamide—SLC22A3—central nervous system—migraine	0.000168	0.00396	CbGeAlD
Procainamide—Hallucination—Topiramate—migraine	0.000168	0.002	CcSEcCtD
Procainamide—Vomiting—Propranolol—migraine	0.000168	0.002	CcSEcCtD
Procainamide—SCN3A—brain—migraine	0.000167	0.00395	CbGeAlD
Procainamide—SLC22A4—Transmembrane transport of small molecules—TRPM8—migraine	0.000167	0.00249	CbGpPWpGaD
Procainamide—SCN5A—brain—migraine	0.000167	0.00393	CbGeAlD
Procainamide—SCN10A—Developmental Biology—SCN1A—migraine	0.000166	0.00247	CbGpPWpGaD
Procainamide—Diarrhoea—Verapamil—migraine	0.000166	0.00198	CcSEcCtD
Procainamide—SLC22A2—Neuronal System—KCNK18—migraine	0.000165	0.00246	CbGpPWpGaD
Procainamide—Anorexia—Valproic Acid—migraine	0.000164	0.00195	CcSEcCtD
Procainamide—SCN5A—Axon guidance—SCN1A—migraine	0.000164	0.00244	CbGpPWpGaD
Procainamide—Ill-defined disorder—Gabapentin—migraine	0.000162	0.00193	CcSEcCtD
Procainamide—Hypotension—Valproic Acid—migraine	0.000161	0.00191	CcSEcCtD
Procainamide—Dizziness—Verapamil—migraine	0.00016	0.00191	CcSEcCtD
Procainamide—Arthralgia—Timolol—migraine	0.00016	0.0019	CcSEcCtD
Procainamide—Myalgia—Timolol—migraine	0.00016	0.0019	CcSEcCtD
Procainamide—Angioedema—Gabapentin—migraine	0.00016	0.0019	CcSEcCtD
Procainamide—SCN9A—Developmental Biology—SCN2A—migraine	0.000159	0.00237	CbGpPWpGaD
Procainamide—Discomfort—Timolol—migraine	0.000158	0.00188	CcSEcCtD
Procainamide—Malaise—Gabapentin—migraine	0.000158	0.00188	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Valproic Acid—migraine	0.000157	0.00187	CcSEcCtD
Procainamide—Cardiac disorder—Topiramate—migraine	0.000157	0.00187	CcSEcCtD
Procainamide—Flushing—Topiramate—migraine	0.000157	0.00187	CcSEcCtD
Procainamide—Nausea—Propranolol—migraine	0.000157	0.00187	CcSEcCtD
Procainamide—CYP2D6—brainstem—migraine	0.000156	0.00368	CbGeAlD
Procainamide—Confusional state—Timolol—migraine	0.000154	0.00184	CcSEcCtD
Procainamide—Vomiting—Verapamil—migraine	0.000154	0.00184	CcSEcCtD
Procainamide—SLC22A1—Neuronal System—KCNK18—migraine	0.000154	0.00229	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—SCN2A—migraine	0.000152	0.00227	CbGpPWpGaD
Procainamide—Chills—Topiramate—migraine	0.000151	0.00181	CcSEcCtD
Procainamide—CHRM2—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000151	0.00226	CbGpPWpGaD
Procainamide—Convulsion—Gabapentin—migraine	0.000151	0.0018	CcSEcCtD
Procainamide—CHRM2—Amine ligand-binding receptors—HTR7—migraine	0.000151	0.00225	CbGpPWpGaD
Procainamide—Shock—Timolol—migraine	0.000151	0.00179	CcSEcCtD
Procainamide—Decreased appetite—Valproic Acid—migraine	0.000149	0.00178	CcSEcCtD
Procainamide—Arthralgia—Gabapentin—migraine	0.000149	0.00177	CcSEcCtD
Procainamide—Myalgia—Gabapentin—migraine	0.000149	0.00177	CcSEcCtD
Procainamide—Discomfort—Gabapentin—migraine	0.000147	0.00175	CcSEcCtD
Procainamide—SLC22A4—brain—migraine	0.000147	0.00346	CbGeAlD
Procainamide—SCN4A—Developmental Biology—SCN2A—migraine	0.000146	0.00218	CbGpPWpGaD
Procainamide—Anorexia—Timolol—migraine	0.000146	0.00174	CcSEcCtD
Procainamide—SCN9A—Developmental Biology—MEF2D—migraine	0.000146	0.00217	CbGpPWpGaD
Procainamide—Nausea—Verapamil—migraine	0.000144	0.00172	CcSEcCtD
Procainamide—Dysgeusia—Topiramate—migraine	0.000144	0.00171	CcSEcCtD
Procainamide—Confusional state—Gabapentin—migraine	0.000144	0.00171	CcSEcCtD
Procainamide—Hypotension—Timolol—migraine	0.000143	0.0017	CcSEcCtD
Procainamide—CHRM2—brain—migraine	0.000142	0.00335	CbGeAlD
Procainamide—Feeling abnormal—Valproic Acid—migraine	0.000142	0.00169	CcSEcCtD
Procainamide—SCN1A—Developmental Biology—SCN2A—migraine	0.000141	0.0021	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—SCN2A—migraine	0.000141	0.0021	CbGpPWpGaD
Procainamide—Gastrointestinal pain—Valproic Acid—migraine	0.000141	0.00168	CcSEcCtD
Procainamide—Shock—Gabapentin—migraine	0.00014	0.00167	CcSEcCtD
Procainamide—SLC22A1—brain—migraine	0.00014	0.00329	CbGeAlD
Procainamide—Thrombocytopenia—Gabapentin—migraine	0.00014	0.00166	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Timolol—migraine	0.000139	0.00166	CcSEcCtD
Procainamide—SCN3A—Developmental Biology—MEF2D—migraine	0.000139	0.00208	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—SCN2A—migraine	0.000139	0.00207	CbGpPWpGaD
Procainamide—Urticaria—Valproic Acid—migraine	0.000137	0.00163	CcSEcCtD
Procainamide—Ill-defined disorder—Topiramate—migraine	0.000136	0.00162	CcSEcCtD
Procainamide—Body temperature increased—Valproic Acid—migraine	0.000136	0.00162	CcSEcCtD
Procainamide—Abdominal pain—Valproic Acid—migraine	0.000136	0.00162	CcSEcCtD
Procainamide—Anorexia—Gabapentin—migraine	0.000136	0.00162	CcSEcCtD
Procainamide—SCN4A—Developmental Biology—MEF2D—migraine	0.000134	0.002	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MEF2D—migraine	0.000134	0.002	CbGpPWpGaD
Procainamide—SLC22A3—brain—migraine	0.000133	0.00314	CbGeAlD
Procainamide—Hypotension—Gabapentin—migraine	0.000133	0.00159	CcSEcCtD
Procainamide—Decreased appetite—Timolol—migraine	0.000133	0.00159	CcSEcCtD
Procainamide—Malaise—Topiramate—migraine	0.000133	0.00158	CcSEcCtD
Procainamide—ACHE—Transmission across Chemical Synapses—CACNA1A—migraine	0.000132	0.00197	CbGpPWpGaD
Procainamide—BCHE—head—migraine	0.00013	0.00307	CbGeAlD
Procainamide—Musculoskeletal discomfort—Gabapentin—migraine	0.00013	0.00155	CcSEcCtD
Procainamide—ACHE—Peptide hormone metabolism—ACE—migraine	0.00013	0.00194	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MEF2D—migraine	0.000129	0.00192	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MEF2D—migraine	0.000129	0.00192	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—HTR3A—migraine	0.000129	0.00192	CbGpPWpGaD
Procainamide—Convulsion—Topiramate—migraine	0.000127	0.00152	CcSEcCtD
Procainamide—SLC22A4—Transmembrane transport of small molecules—ATP1A3—migraine	0.000127	0.00189	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—ATP1A2—migraine	0.000127	0.00189	CbGpPWpGaD
Procainamide—Hypersensitivity—Valproic Acid—migraine	0.000127	0.00151	CcSEcCtD
Procainamide—SLC22A3—Transmembrane transport of small molecules—TRPM8—migraine	0.000126	0.00188	CbGpPWpGaD
Procainamide—Feeling abnormal—Timolol—migraine	0.000126	0.0015	CcSEcCtD
Procainamide—SLC22A5—Transmembrane transport of small molecules—TRPM8—migraine	0.000126	0.00187	CbGpPWpGaD
Procainamide—CHRM2—Monoamine GPCRs—HTR2A—migraine	0.000126	0.00187	CbGpPWpGaD
Procainamide—Gastrointestinal pain—Timolol—migraine	0.000125	0.00149	CcSEcCtD
Procainamide—Myalgia—Topiramate—migraine	0.000125	0.00149	CcSEcCtD
Procainamide—Arthralgia—Topiramate—migraine	0.000125	0.00149	CcSEcCtD
Procainamide—Decreased appetite—Gabapentin—migraine	0.000124	0.00148	CcSEcCtD
Procainamide—BCHE—nervous system—migraine	0.000124	0.00291	CbGeAlD
Procainamide—Discomfort—Topiramate—migraine	0.000124	0.00147	CcSEcCtD
Procainamide—Asthenia—Valproic Acid—migraine	0.000123	0.00147	CcSEcCtD
Procainamide—Pruritus—Valproic Acid—migraine	0.000122	0.00145	CcSEcCtD
Procainamide—Urticaria—Timolol—migraine	0.000122	0.00145	CcSEcCtD
Procainamide—Abdominal pain—Timolol—migraine	0.000121	0.00144	CcSEcCtD
Procainamide—Body temperature increased—Timolol—migraine	0.000121	0.00144	CcSEcCtD
Procainamide—Confusional state—Topiramate—migraine	0.000121	0.00144	CcSEcCtD
Procainamide—SLC22A5—cerebellum—migraine	0.000119	0.00282	CbGeAlD
Procainamide—BCHE—central nervous system—migraine	0.000119	0.00281	CbGeAlD
Procainamide—SCN5A—SIDS Susceptibility Pathways—HTR1A—migraine	0.000119	0.00177	CbGpPWpGaD
Procainamide—Shock—Topiramate—migraine	0.000118	0.00141	CcSEcCtD
Procainamide—BCHE—Transmission across Chemical Synapses—CACNA1A—migraine	0.000118	0.00176	CbGpPWpGaD
Procainamide—Diarrhoea—Valproic Acid—migraine	0.000118	0.0014	CcSEcCtD
Procainamide—Feeling abnormal—Gabapentin—migraine	0.000117	0.0014	CcSEcCtD
Procainamide—Thrombocytopenia—Topiramate—migraine	0.000117	0.0014	CcSEcCtD
Procainamide—SCN5A—SIDS Susceptibility Pathways—TAC1—migraine	0.000117	0.00174	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—SCN1A—migraine	0.000117	0.00174	CbGpPWpGaD
Procainamide—Gastrointestinal pain—Gabapentin—migraine	0.000117	0.00139	CcSEcCtD
Procainamide—BCHE—cerebellum—migraine	0.000116	0.00274	CbGeAlD
Procainamide—BCHE—Peptide hormone metabolism—ACE—migraine	0.000116	0.00173	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000115	0.00171	CbGpPWpGaD
Procainamide—Anorexia—Topiramate—migraine	0.000114	0.00136	CcSEcCtD
Procainamide—Dizziness—Valproic Acid—migraine	0.000114	0.00136	CcSEcCtD
Procainamide—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000114	0.00169	CbGpPWpGaD
Procainamide—Urticaria—Gabapentin—migraine	0.000113	0.00135	CcSEcCtD
Procainamide—Hypersensitivity—Timolol—migraine	0.000113	0.00134	CcSEcCtD
Procainamide—Body temperature increased—Gabapentin—migraine	0.000113	0.00134	CcSEcCtD
Procainamide—Abdominal pain—Gabapentin—migraine	0.000113	0.00134	CcSEcCtD
Procainamide—Hypotension—Topiramate—migraine	0.000112	0.00134	CcSEcCtD
Procainamide—Asthenia—Timolol—migraine	0.00011	0.00131	CcSEcCtD
Procainamide—Vomiting—Valproic Acid—migraine	0.000109	0.0013	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Topiramate—migraine	0.000109	0.0013	CcSEcCtD
Procainamide—Pruritus—Timolol—migraine	0.000108	0.00129	CcSEcCtD
Procainamide—SLC22A4—Transmembrane transport of small molecules—HTR3A—migraine	0.000108	0.00161	CbGpPWpGaD
Procainamide—CHRM2—Amine ligand-binding receptors—HTR2A—migraine	0.000106	0.00157	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—CACNA1A—migraine	0.000105	0.00157	CbGpPWpGaD
Procainamide—Hypersensitivity—Gabapentin—migraine	0.000105	0.00125	CcSEcCtD
Procainamide—Diarrhoea—Timolol—migraine	0.000105	0.00125	CcSEcCtD
Procainamide—Decreased appetite—Topiramate—migraine	0.000104	0.00124	CcSEcCtD
Procainamide—ACHE—ATF-2 transcription factor network—ESR1—migraine	0.000103	0.00154	CbGpPWpGaD
Procainamide—Asthenia—Gabapentin—migraine	0.000102	0.00122	CcSEcCtD
Procainamide—Nausea—Valproic Acid—migraine	0.000102	0.00122	CcSEcCtD
Procainamide—Dizziness—Timolol—migraine	0.000101	0.00121	CcSEcCtD
Procainamide—ACHE—Neuronal System—CACNA1A—migraine	0.000101	0.00151	CbGpPWpGaD
Procainamide—Pruritus—Gabapentin—migraine	0.000101	0.0012	CcSEcCtD
Procainamide—SCN5A—Developmental Biology—SCN2A—migraine	9.93e-05	0.00148	CbGpPWpGaD
Procainamide—Feeling abnormal—Topiramate—migraine	9.88e-05	0.00118	CcSEcCtD
Procainamide—SLC22A1—Transmission across Chemical Synapses—CACNA1A—migraine	9.81e-05	0.00146	CbGpPWpGaD
Procainamide—Gastrointestinal pain—Topiramate—migraine	9.81e-05	0.00117	CcSEcCtD
Procainamide—Diarrhoea—Gabapentin—migraine	9.75e-05	0.00116	CcSEcCtD
Procainamide—Vomiting—Timolol—migraine	9.73e-05	0.00116	CcSEcCtD
Procainamide—SLC22A5—brain—migraine	9.7e-05	0.00229	CbGeAlD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ATP1A2—migraine	9.56e-05	0.00142	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ATP1A3—migraine	9.56e-05	0.00142	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ATP1A2—migraine	9.53e-05	0.00142	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ATP1A3—migraine	9.53e-05	0.00142	CbGpPWpGaD
Procainamide—Urticaria—Topiramate—migraine	9.53e-05	0.00114	CcSEcCtD
Procainamide—Body temperature increased—Topiramate—migraine	9.48e-05	0.00113	CcSEcCtD
Procainamide—Abdominal pain—Topiramate—migraine	9.48e-05	0.00113	CcSEcCtD
Procainamide—BCHE—brain—migraine	9.45e-05	0.00223	CbGeAlD
Procainamide—Dizziness—Gabapentin—migraine	9.43e-05	0.00112	CcSEcCtD
Procainamide—ACHE—ATF-2 transcription factor network—FOS—migraine	9.3e-05	0.00139	CbGpPWpGaD
Procainamide—Nausea—Timolol—migraine	9.09e-05	0.00108	CcSEcCtD
Procainamide—SCN5A—Developmental Biology—MEF2D—migraine	9.08e-05	0.00135	CbGpPWpGaD
Procainamide—Vomiting—Gabapentin—migraine	9.06e-05	0.00108	CcSEcCtD
Procainamide—BCHE—Neuronal System—CACNA1A—migraine	9.03e-05	0.00135	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Other—EDNRA—migraine	8.85e-05	0.00132	CbGpPWpGaD
Procainamide—Hypersensitivity—Topiramate—migraine	8.84e-05	0.00105	CcSEcCtD
Procainamide—CYP2D6—head—migraine	8.64e-05	0.00204	CbGeAlD
Procainamide—Asthenia—Topiramate—migraine	8.6e-05	0.00103	CcSEcCtD
Procainamide—Pruritus—Topiramate—migraine	8.49e-05	0.00101	CcSEcCtD
Procainamide—Nausea—Gabapentin—migraine	8.47e-05	0.00101	CcSEcCtD
Procainamide—SCN5A—SIDS Susceptibility Pathways—BDNF—migraine	8.32e-05	0.00124	CbGpPWpGaD
Procainamide—Diarrhoea—Topiramate—migraine	8.21e-05	0.000978	CcSEcCtD
Procainamide—CYP2D6—nervous system—migraine	8.19e-05	0.00193	CbGeAlD
Procainamide—ACHE—Monoamine Transport—TNF—migraine	8.15e-05	0.00121	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—HTR3A—migraine	8.13e-05	0.00121	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—HTR3A—migraine	8.1e-05	0.00121	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—CACNA1A—migraine	8.06e-05	0.0012	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Other—HTR7—migraine	7.97e-05	0.00119	CbGpPWpGaD
Procainamide—Dizziness—Topiramate—migraine	7.93e-05	0.000945	CcSEcCtD
Procainamide—SLC22A2—Transmembrane transport of small molecules—TRPM8—migraine	7.91e-05	0.00118	CbGpPWpGaD
Procainamide—CYP2D6—central nervous system—migraine	7.89e-05	0.00186	CbGeAlD
Procainamide—CYP2D6—cerebellum—migraine	7.71e-05	0.00182	CbGeAlD
Procainamide—Vomiting—Topiramate—migraine	7.63e-05	0.000909	CcSEcCtD
Procainamide—CHRM2—G alpha (i) signalling events—HTR1D—migraine	7.56e-05	0.00113	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—CACNA1A—migraine	7.52e-05	0.00112	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—TRPM8—migraine	7.38e-05	0.0011	CbGpPWpGaD
Procainamide—Nausea—Topiramate—migraine	7.12e-05	0.000849	CcSEcCtD
Procainamide—SCN5A—SIDS Susceptibility Pathways—HTR2A—migraine	7.03e-05	0.00105	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	7.02e-05	0.00105	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	6.52e-05	0.000972	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—RAMP1—migraine	6.3e-05	0.000939	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CALCRL—migraine	6.3e-05	0.000939	CbGpPWpGaD
Procainamide—CYP2D6—brain—migraine	6.26e-05	0.00148	CbGeAlD
Procainamide—CHRM2—SIDS Susceptibility Pathways—HTR1A—migraine	6.12e-05	0.000912	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TAC1—migraine	6.03e-05	0.000898	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	6.01e-05	0.000896	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ATP1A3—migraine	6e-05	0.000894	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ATP1A2—migraine	6e-05	0.000894	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—SLC6A4—migraine	5.91e-05	0.000881	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	5.59e-05	0.000833	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ATP1A3—migraine	5.59e-05	0.000833	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ATP1A2—migraine	5.59e-05	0.000833	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Other—HTR2A—migraine	5.58e-05	0.000832	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—migraine	5.37e-05	0.000801	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—HTR3A—migraine	5.1e-05	0.00076	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—NOTCH4—migraine	4.8e-05	0.000715	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—HTR3A—migraine	4.75e-05	0.000708	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—HTR1B—migraine	4.58e-05	0.000683	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR1D—migraine	4.58e-05	0.000682	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—HTR1A—migraine	4.41e-05	0.000657	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—PGR—migraine	4.39e-05	0.000654	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—BDNF—migraine	4.29e-05	0.00064	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR2B—migraine	4.26e-05	0.000634	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	4.25e-05	0.000634	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	4.09e-05	0.00061	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—NOTCH3—migraine	4.08e-05	0.000608	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—migraine	4.03e-05	0.0006	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	3.95e-05	0.000589	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	3.85e-05	0.000573	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	3.64e-05	0.000543	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—HTR2A—migraine	3.63e-05	0.00054	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—RAMP1—migraine	3.56e-05	0.000531	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CALCRL—migraine	3.56e-05	0.000531	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	3.51e-05	0.000523	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	3.46e-05	0.000516	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	3.45e-05	0.000515	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	3.45e-05	0.000515	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	3.39e-05	0.000505	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	3.29e-05	0.000491	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CACNA1A—migraine	3.24e-05	0.000482	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CALCRL—migraine	3.23e-05	0.000482	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—RAMP1—migraine	3.23e-05	0.000482	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—TNF—migraine	3.02e-05	0.000451	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	2.97e-05	0.000442	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TNF—migraine	2.93e-05	0.000436	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR1B—migraine	2.77e-05	0.000413	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR1A—migraine	2.67e-05	0.000398	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—TAC1—migraine	2.63e-05	0.000392	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—NPS—migraine	2.63e-05	0.000392	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TNF—migraine	2.61e-05	0.000389	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR1D—migraine	2.59e-05	0.000386	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR2C—migraine	2.58e-05	0.000384	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CACNA1A—migraine	2.55e-05	0.00038	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—EDNRA—migraine	2.51e-05	0.000374	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—ACE—migraine	2.45e-05	0.000365	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	2.42e-05	0.000361	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CALCA—migraine	2.41e-05	0.00036	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2B—migraine	2.41e-05	0.000358	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TNF—migraine	2.39e-05	0.000356	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR1D—migraine	2.35e-05	0.00035	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—ESR1—migraine	2.34e-05	0.000349	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CACNA1A—migraine	2.27e-05	0.000339	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR7—migraine	2.26e-05	0.000337	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—ACE—migraine	2.19e-05	0.000326	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2B—migraine	2.18e-05	0.000326	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.08e-05	0.00031	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CACNA1A—migraine	2.03e-05	0.000303	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.95e-05	0.000291	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TNF—migraine	1.93e-05	0.000288	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CALCRL—migraine	1.91e-05	0.000285	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RAMP1—migraine	1.91e-05	0.000285	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CACNA1A—migraine	1.89e-05	0.000282	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TNF—migraine	1.85e-05	0.000275	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TNF—migraine	1.77e-05	0.000264	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TNF—migraine	1.77e-05	0.000264	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TNF—migraine	1.71e-05	0.000255	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TNF—migraine	1.71e-05	0.000255	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR2A—migraine	1.58e-05	0.000236	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR1B—migraine	1.57e-05	0.000234	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TNF—migraine	1.56e-05	0.000232	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR1A—migraine	1.51e-05	0.000225	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TAC1—migraine	1.49e-05	0.000221	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—NPS—migraine	1.49e-05	0.000221	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2C—migraine	1.46e-05	0.000217	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR1B—migraine	1.42e-05	0.000212	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—EDNRA—migraine	1.42e-05	0.000211	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR1D—migraine	1.39e-05	0.000207	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR1A—migraine	1.37e-05	0.000204	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CALCA—migraine	1.36e-05	0.000203	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TAC1—migraine	1.35e-05	0.000201	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—NPS—migraine	1.35e-05	0.000201	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2C—migraine	1.32e-05	0.000197	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2B—migraine	1.29e-05	0.000192	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EDNRA—migraine	1.29e-05	0.000192	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR7—migraine	1.28e-05	0.00019	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CALCA—migraine	1.24e-05	0.000185	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—migraine	1.2e-05	0.000179	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR7—migraine	1.16e-05	0.000173	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LRP1—migraine	1.14e-05	0.000169	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MTHFR—migraine	1.07e-05	0.00016	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CACNA1A—migraine	1.05e-05	0.000156	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2A—migraine	8.94e-06	0.000133	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOTCH4—migraine	8.72e-06	0.00013	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—migraine	8.43e-06	0.000126	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR1B—migraine	8.41e-06	0.000125	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2A—migraine	8.12e-06	0.000121	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR1A—migraine	8.1e-06	0.000121	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TAC1—migraine	7.97e-06	0.000119	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NPS—migraine	7.97e-06	0.000119	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PGR—migraine	7.97e-06	0.000119	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2C—migraine	7.82e-06	0.000117	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDNRA—migraine	7.61e-06	0.000113	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—migraine	7.52e-06	0.000112	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOTCH3—migraine	7.41e-06	0.00011	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CALCA—migraine	7.32e-06	0.000109	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR7—migraine	6.85e-06	0.000102	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—migraine	6.72e-06	0.0001	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—migraine	6.26e-06	9.33e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFBR2—migraine	5.9e-06	8.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2A—migraine	4.8e-06	7.15e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ESR1—migraine	4.26e-06	6.34e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—migraine	3.46e-06	5.15e-05	CbGpPWpGaD
